Literature DB >> 35923719

Reactivity-based chemical-genetic study of protein kinases.

Renata Rezende Miranda1,2, Chao Zhang1,3.   

Abstract

The human protein kinase superfamily comprises over 500 members that operate in nearly every signal transduction pathway and regulate essential cellular processes. Deciphering the functional roles of protein kinases with small-molecule inhibitors is essential to enhance our understanding of cell signaling and to facilitate the development of new therapies. However, it is rather challenging to identify selective kinase inhibitors because of the conserved nature of the ATP binding site. A number of chemical-genetic approaches have been developed during the past two decades to enable selective chemical perturbation of the activity of individual kinases. Herein, we review the development and application of chemical-genetic strategies that feature the use of covalent inhibitors targeting cysteine residues to dissect the cellular functions of protein kinases. This journal is © The Royal Society of Chemistry.

Entities:  

Year:  2022        PMID: 35923719      PMCID: PMC9298188          DOI: 10.1039/d1md00389e

Source DB:  PubMed          Journal:  RSC Med Chem        ISSN: 2632-8682


  82 in total

Review 1.  Chemical genetics: ligand-based discovery of gene function.

Authors:  B R Stockwell
Journal:  Nat Rev Genet       Date:  2000-11       Impact factor: 53.242

Review 2.  Gene overexpression: uses, mechanisms, and interpretation.

Authors:  Gregory Prelich
Journal:  Genetics       Date:  2012-03       Impact factor: 4.562

Review 3.  Developing irreversible inhibitors of the protein kinase cysteinome.

Authors:  Qingsong Liu; Yogesh Sabnis; Zheng Zhao; Tinghu Zhang; Sara J Buhrlage; Lyn H Jones; Nathanael S Gray
Journal:  Chem Biol       Date:  2013-02-21

Review 4.  The logic and design of analog-sensitive kinases and their small molecule inhibitors.

Authors:  Michael S Lopez; Joseph I Kliegman; Kevan M Shokat
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

5.  Type II Kinase Inhibitors Targeting Cys-Gatekeeper Kinases Display Orthogonality with Wild Type and Ala/Gly-Gatekeeper Kinases.

Authors:  Cory A Ocasio; Alexander A Warkentin; Patrick J McIntyre; Krister J Barkovich; Clare Vesely; John Spencer; Kevan M Shokat; Richard Bayliss
Journal:  ACS Chem Biol       Date:  2018-10-09       Impact factor: 5.100

Review 6.  Small-Molecule Target Engagement in Cells.

Authors:  Marc Schürmann; Petra Janning; Slava Ziegler; Herbert Waldmann
Journal:  Cell Chem Biol       Date:  2016-03-31       Impact factor: 8.116

Review 7.  Progress with covalent small-molecule kinase inhibitors.

Authors:  Zheng Zhao; Philip E Bourne
Journal:  Drug Discov Today       Date:  2018-01-11       Impact factor: 7.851

8.  Importance of Quantifying Drug-Target Engagement in Cells.

Authors:  Jakub Stefaniak; Kilian V M Huber
Journal:  ACS Med Chem Lett       Date:  2020-03-06       Impact factor: 4.345

9.  A Combined Approach Reveals a Regulatory Mechanism Coupling Src's Kinase Activity, Localization, and Phosphotransferase-Independent Functions.

Authors:  Ethan Ahler; Ames C Register; Sujata Chakraborty; Linglan Fang; Emily M Dieter; Katherine A Sitko; Rama Subba Rao Vidadala; Bridget M Trevillian; Martin Golkowski; Hannah Gelman; Jason J Stephany; Alan F Rubin; Ethan A Merritt; Douglas M Fowler; Dustin J Maly
Journal:  Mol Cell       Date:  2019-04-04       Impact factor: 17.970

10.  Structure- and reactivity-based development of covalent inhibitors of the activating and gatekeeper mutant forms of the epidermal growth factor receptor (EGFR).

Authors:  Richard A Ward; Mark J Anderton; Susan Ashton; Paul A Bethel; Matthew Box; Sam Butterworth; Nicola Colclough; Christopher G Chorley; Claudio Chuaqui; Darren A E Cross; Les A Dakin; Judit É Debreczeni; Cath Eberlein; M Raymond V Finlay; George B Hill; Matthew Grist; Teresa C M Klinowska; Clare Lane; Scott Martin; Jonathon P Orme; Peter Smith; Fengjiang Wang; Michael J Waring
Journal:  J Med Chem       Date:  2013-08-30       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.